tricare semaglutide coverage Does Cover Weight Loss Pills in 2026? We Now Accept TriCare Prime

doi: 10.1371/journal.pone.0147509 52 MondanelliGBianchiRPallottaMTOrabonaCAlbiniEIaconoAet al

#Retatrutide, the triple-G (GLP-1, GIP, and glucagon receptor) agonist caused patients with obesity and knee osteoarthritis to lose an average of 23.7% of body weight after 68 weeks, according to the results of one of the several phase 3 clinical trials published by Eli Lilly

* Please note that our office does not accept Medicare or insurance and that we are a fully cash-based practice

Statements Data availability statement The data supporting the findings of this study are not publicly available due to ethical and legal restrictions related to patient privacy and institutional regulations